Senators Ask Justice Department to Investigate EpiPen maker

Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its life-saving EpiPen as a generic drug and qualified for lower rebate payments to states.

Senate Judiciary Committee Chairman Charles Grassley and two other senators have sent a letter to Attorney General Loretta Lynch and suggested the company may have gamed the system to divert millions of dollars from taxpayers.

Mylan CEO Heather Bresch has come under fire in Congress as the price of the emergency allergy shots has skyrocketed in recent years.

The list price of EpiPens has grown to $608 for a two-pack, an increase of more than 500 percent since 2007.

(Copyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)